Element Science
Private Company
Total funding raised: $261.1M
Overview
Element Science is a private, commercial-stage medical device company pioneering wearable technology for cardiovascular emergencies. Its core innovation is the Jewel® P-WCD, a sleek, adhesive-based wearable defibrillator that has received FDA approval and is available in limited U.S. markets. The company operates at the intersection of cardiovascular medicine and digital health, aiming to provide continuous, comfortable protection for at-risk patients. Its mission is to reduce mortality from sudden cardiac arrest through accessible, user-centric wearable technology.
Technology Platform
Wearable Patch Cardioverter Defibrillator (P-WCD) platform integrating adhesive-based wearable design, arrhythmia detection algorithms, and therapy delivery for sudden cardiac arrest protection.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Element Science competes directly with traditional wearable cardioverter defibrillator manufacturers like Zoll Medical (a subsidiary of Asahi Kasei). It also faces indirect competition from implantable cardioverter defibrillator (ICD) makers (Medtronic, Boston Scientific, Abbott) and must demonstrate its value proposition for the temporary-risk patient population where ICDs are not yet indicated.